Immunoglobulin isotype-specific characterization of anti-human leukocyte antigen antibodies eluted from explanted renal allografts

Human Immunology

Volumn 68, Issue 6, 2007, Pages 500-506

  Heinemann, Falko M ^a   Roth, Ioana ^a   Rebmann, Vera ^a   Arnold, Marie Luise ^b   Witzke, Oliver ^a   Wilde, Benjamin ^a   Spriewald, Bernd M ^b   Grosse Wilde, Hans ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Acid protein elution; Anti HLA antibodies; Kidney transplantation; Non complement binding antibodies

Indexed keywords

HLA ANTIBODY; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G4;

ADULT; ANTIBODY ISOLATION; ANTIBODY SCREENING; ARTICLE; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; KIDNEY ALLOGRAFT; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN ISOLATION;

FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOGLOBULIN G; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; TRANSPLANTATION, HOMOLOGOUS;

EID: 34248146139     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2007.02.007     Document Type: Article

References (29)

1. Kissmeyer-Nielsen F., Olsen S., Petersen V.P., and Fjeldborg O. Hyperacute rejection of kidney allografts associated with pre-existing humoral antibodies against donor cells. Lancet 2 (1966) 662
2. Patel R., and Terasaki P.I. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 280 (1969) 735
3. Martin S., Dyer P.A., Mallick N.P., Gokal R., Harris R., and Johnson R.W. Post-transplant antidonor lymphocytotoxic antibody production in relation to graft outcome. Transplantation 44 (1987) 50
4. Halloran P.F., Schlaut J., Solez K., and Srinivasa N.S. The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplantation 53 (1992) 550
5. Garovoy M.R., Gailiunas P., Carpenter C.B., and Busch G.J. Immunologic monitoring of transplant rejection: correlation of in vitro assays with morphologic changes on transplant biopsy. Nephron 22 (1978) 208
6. Andres G.A., Accinni L., Hsu K.C., Penn I., Porter K.A., Rendall J.M., Seegal B.C., and Starzl T.E. Human renal transplants. 3. Immunopathologic studies. Lab Invest 22 (1970) 588
7. Worthington J.E., Martin S., Al-Husseini D.M., Dyer P.A., and Johnson R.W. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome. Transplantation 75 (2003) 1034
8. Terasaki P.I., and McClelland J.D. Microdroplet assay of human serum cytotoxins. Nature 204 (1964) 998
9. Zachary A.A., Ratner L.E., Graziani J.A., Lucas D.P., Delaney N.L., and Leffell M.S. Characterization of HLA class I specific antibodies by ELISA using solubilized antigen targets: II. Clinical relevance. Hum Immunol 62 (2001) 236
10. Pei R., Lee J.H., Shih N.J., Chen M., and Terasaki P.I. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 75 (2003) 43
11. Karuppan S.S., Ohlman S., and Moller E. The occurrence of cytotoxic and non-complement-fixing antibodies in the crossmatch serum of patients with early acute rejection episodes. Transplantation 54 (1992) 839
12. Koka P., Chia D., Terasaki P.I., Chan H., Chia J., and Ozawa M. The role of IgA anti-HLA class I antibodies in kidney transplant survival. Transplantation 56 (1993) 207
13. Lucchiari N., Panajotopoulos N., Xu C., Rodrigues H., Ianhez L.E., Kalil J., and Glotz D. Antibodies eluted from acutely rejected renal allografts bind to and activate human endothelial cells. Hum Immunol 61 (2000) 518
14. Opelz G. Collaborative Transplant Study. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 365 (2005) 1570
15. Mizutani K., Terasaki P., Rosen A., Esquenazi V., Miller J., Shih R.N., Pei R., Ozawa M., and Lee J. Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure. Am J Transplant 9 (2005) 2265
16. Zou Y., Heinemann F.M., Grosse-Wilde H., Sireci G., Wang Z., Lavingia B., and Stastny P. Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts by Luminex flow cytometry. Hum Immunol 67 (2006) 230
17. Vögeler U., Doxiadis I., Buchholz B., Eigler F.W., Lison W., Niebel W., Zastrow F., and Grosse-Wilde H. Cytotoxicity of antibodies eluted from rejected kidney allografts. Transpl Proc 17 (1985) 2630
18. Martin L., Guignier F., Mousson C., Rageot D., Justrabo E., and Rifle G. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy. Transplantation 76 (2003) 395
19. Martin L., Guignier F., Bocrie O., D'Athis P., Rageot D., Rifle G., Justrabo E., and Mousson C. Detection of anti-HLA antibodies with flow cytometry in needle core biopsies of renal transplants recipients with chronic allograft nephropathy. Transplantation 79 (2005) 1459
20. Arnold M.L., Zacher T., Dechant M., Kalden J.R., Doxiadis I.I., and Spriewald B.M. Detection and specification of noncomplement binding anti-HLA alloantibodies. Hum Immunol 65 (2004) 1288
21. Dechant M., Vidarsson G., Stockmeyer B., Repp R., Glennie M.J., Gramatzki M., van De Winkel J.G., and Valerius T. Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing. Blood 100 (2002) 4574
22. Feucht H.E., and Opelz G. The humoral immune response towards HLA class II determinants in renal transplantation. Kidney Int 50 (1996) 1464
23. Cecka J.M., and Terasaki P.I. Repeating HLA antigen mismatches in renal retransplants-a second class mistake?. Transplantation 57 (1994) 515
24. Fuller A., Profaizer T., Roberts L., and Fuller T.C. Repeat donor HLA-DR mismatches in renal transplantation is the increased failure rate caused by noncytotoxic HLA-DR alloantibodies?. Transplantation 68 (1999) 589
25. Malisan F., Briere F., Bridon J.M., Harindranath N., Mills F.C., Max E.E., Banchereau J., and Martinez-Valdez H. Interleukin-10 induces immunoglobulin G isotype switch recombination in human CD40-activated naive B lymphocytes. J Exp Med 183 (1996) 937
26. Susal C., Dohler B., and Opelz G. Graft-protective role of high pretransplantation IgA-anti-Fab autoantibodies: confirmatory evidence obtained in more than 4000 kidney transplants. The Collaborative Transplant Study. Transplantation 69 (2000) 1337
27. Lim E.C., Chia D., Gjertson D.W., Koka P., and Terasaki P.I. In vitro studies to explain high renal allograft survival in IgA nephropathy patients. Transplantation 55 (1993) 996
28. Andresdottir M.B., Haasnoot G.W., Doxiadis I.I., Persijn G.G., and Claas F.H. Exclusive characteristics of graft survival and risk factors in recipients with Immunoglobulin A nephropathy: a retrospective analysis of registry data. Transplantation 80 (2005) 1012
29. Ponticelli C., Traversi L., Feliciani A., Cesana B.M., Banfi G., and Tarantino A. Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int 60 (2001) 1948